Growth Metrics

RemSleep Holdings (RMSL) Depreciation & Amortization (IS) (2015 - 2016)

RemSleep Holdings recorded quarterly Depreciation & Amortization (IS) of $229.0 in Q3 2016, little changed quarter-over-quarter from $230.0 in Q2 2016, and little changed year-over-year from $230.0 in Q4 2015.

RemSleep Holdings' Depreciation & Amortization (IS) history runs 2 years deep, the most recent figure standing at $229.0 for Q3 2016.

  • In Q3 2016, Depreciation & Amortization (IS) changed 0.43% year-over-year to $229.0; the TTM figure through Sep 2016 stood at $914.0 (changed N/A YoY), while the FY2015 annual figure was $914.0, up 300.88% from the prior year.
  • Depreciation & Amortization (IS) came in at $229.0 for Q3 2016 at RemSleep Holdings, roughly flat from $230.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (IS) ranged from a high of $230.0 in Q3 2015 to a low of $226.0 in Q4 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 310.25 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 RemSleep Holdings - - -7,636.00 -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2016 229.00
Jun 30, 2016 230.00
Mar 31, 2016 229.00
Dec 31, 2015 226.00
Sep 30, 2015 230.00
Jun 30, 2015 229.00
Mar 31, 2015 229.00